Browse result page of CancerPDF Database

Please click on CancerPDF_ID for detailed information about peptide.

CancerPDF_IDPeptide seqProtein NameFluidMass/ZProfiling TechniqueCancer Type Expression RegulationPUBMED ID
CancerPDF_ID100 ALGISPFHEHAEVVFTANDSGPRTransthyretin precursor (‘prealbumin’)Serum2451.11MALDI-TOFMetastatic thyroid carcinomas NA 16896061
CancerPDF_ID158 VKVLDAVRGSPAINTransthyretin (prealbumin)PlasmaNAMALDI-TOFNormal NA 17269714
CancerPDF_ID333 ADDTWEPFASGKTSESGELHTransthyretinPlasma721.981LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID334 ADDTWEPFASGKTransthyretinPlasma662.293LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID335 DDTWEPFASGKTSESGELHTransthyretinPlasma698.3033333LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID336 DDTWEPFASGKTSESGETransthyretinPlasma921.8835LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID337 SPAINVAVHVTransthyretinPlasma503.7845LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID338 AINVAVHVTransthyretinPlasma411.742LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID339 ASGKTSESGELHGLTTEEEFTransthyretinPlasma703.654LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID340 GLTTEEEFVEGIYKVEIDTKTransthyretinPlasma1150.5775LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID341 GLTTEEEFVEGIYKTransthyretinPlasma807.895LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID342 VEGIYKVEITransthyretinPlasma525.294LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID343 SYSTTAVVTNPKETransthyretinPlasma698.848LC-MSDuctal adenocarcinoma of the pancreas (DAP) NA 19795908
CancerPDF_ID1096 ALGISPFHEHAEVVFTANDSGPRTranstherin precursor (‘prealbumin’)Serum2451.11MALDI-TOF"Advanced Prostate, Breast and Bladder cancer" "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =0.02, 1.17 and 3.07 in prostate, bladder and breast cancer respectively" 16395409
CancerPDF_ID2105 AADDTWEPFASGKTransthyretinSerum1393.61501LC-MSColorectal cancer NA 21136997
CancerPDF_ID2106 ADDTWEPFASGKTransthyretinSerum1322.5779LC-MSColorectal cancer NA 21136997
CancerPDF_ID2107 ALGISPFHEHAEVVFTANDSGPRTransthyretinSerum2450.19787LC-MSColorectal cancer NA 21136997
CancerPDF_ID2108 YTIAALLSPYSYSTTAVVTNPKETransthyretinSerum2488.27372LC-MSColorectal cancer NA 21136997
CancerPDF_ID2109 GSPAINVAVHVFTransthyretinSerum1209.65061LC-MSColorectal cancer NA 21136997
CancerPDF_ID2110 DDTWEPFASGKTransthyretinSerum1251.54078LC-MSColorectal cancer NA 21136997
CancerPDF_ID2111 AALLSPYSYSTTAVVTNPKETransthyretinSerum2111.07865LC-MSColorectal cancer NA 21136997
CancerPDF_ID3200 GSPAINVAVHVFTransthyretinPlasma1209.6506LC-MSNormal NA 21136997
CancerPDF_ID3201 ADDTWEPFASGKTransthyretinPlasma1322.5779LC-MSNormal NA 21136997
CancerPDF_ID3202 KAADDTWEPFASGKTransthyretinPlasma1521.71LC-MSNormal NA 21136997
CancerPDF_ID3203 VLDAVRGSPAINVAVHVFTransthyretinPlasma1863.0367LC-MSNormal NA 21136997
CancerPDF_ID3204 ALGISPFHEHAEVVFTANDSGPRTransthyretinPlasma2450.1979LC-MSNormal NA 21136997
CancerPDF_ID3205 TSESGELHGLTTEEEFVEGIYKTransthyretinPlasma2454.1438LC-MSNormal NA 21136997
CancerPDF_ID3206 YTIAALLSPYSYSTTAVVTNPKETransthyretinPlasma2488.2737LC-MSNormal NA 21136997
CancerPDF_ID3207 TSESGELHGLTTEEEFVEGIYKVEIDTKTransthyretinPlasma3139.5085LC-MSNormal NA 21136997
CancerPDF_ID4061 AALLSPYSYSTTAVVTNPKETransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID4406 AVHVFRKAADDTWEPFTransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID4683 DTKSYWKALGISPFTransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID4741 EIDTKSYWKALGISPFTransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID5258 GPTGTGESKCPLMTransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID5259 GPTGTGESKCPLMVKVLDAVRGSPAINTransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID5260 GPTGTGESKCPLMVKVLDAVRGSPAINVATransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID5261 GPTGTGESKCPLMVKVLDAVRGSPAINVAVHTransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID5430 IDTKSYWKALGISPFHEHAETransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID5935 LLSPYSYSTTATransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID6236 MVKVLDAVRGSPAINVTransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID7861 VKVLDAVRGSPAINVTransthyretinUrineNANano-LC-MSOvarian cancer Uniquely present in case of urine of ovarian cancer patients 24982608
CancerPDF_ID8586 ALGISPFHEHAEVVFTANDSGPRTransthyretinSerum2450.2MALDI-TOF"Breast cancer, Lung cancer, Rectal cancer" NA 23667664
CancerPDF_ID8587 DSGPRRYTIAALLSPYSYSTTAVVTNPKETransthyretinSerum3156.61MALDI-TOF"Breast cancer, Lung cancer, Rectal cancer" NA 23667664
CancerPDF_ID8588 ALLSPYSYSTTAVVTNPKETransthyretinSerum2040.04MALDI-TOF"Breast cancer, Lung cancer, Rectal cancer" NA 23667664
CancerPDF_ID8589 SYSTTAVVTNPKETransthyretinSerum1395.69MALDI-TOF"Breast cancer, Lung cancer, Rectal cancer" NA 23667664
CancerPDF_ID8590 SYSTTAVVTNPKETransthyretinSerum1409.7MALDI-TOF"Breast cancer, Lung cancer, Rectal cancer" NA 23667664
CancerPDF_ID8604 VKVLDAVRGSPAINPrealbuminSerum1437.83MALDI-TOF"Breast cancer, Lung cancer, Rectal cancer" NA 23667664
CancerPDF_ID8605 VVTNPKEPrealbuminSerum785.43MALDI-TOF"Breast cancer, Lung cancer, Rectal cancer" NA 23667664
CancerPDF_ID8647 SGPRRYTIAALLSPYSYSTTAVVTNPKETransthretin ( Cterminal fragment of protein TTHY)Cerbrospinal fluidNAMALDI-TOFGlioblastoma (Malignant brain tumor) Upregulated in cancer as compare to normal control 19674866
CancerPDF_ID8675 ADDTWEPFASGKTSESTransthyretinAscites fluidNALTQ-Orbitrap XLOvarian cancer Uniquely expressed in ovarian cancer patient 24694173
CancerPDF_ID8686 AEVVFTANDSGPRRYTTransthyretinAscites fluidNALTQ-Orbitrap XLOvarian cancer Uniquely expressed in ovarian cancer patient 24694173
CancerPDF_ID8744 DDTWEPFASGKTSESTransthyretinAscites fluidNALTQ-Orbitrap XLOvarian cancer Uniquely expressed in ovarian cancer patient 24694173
CancerPDF_ID8863 GELHGLTTEEEFTransthyretinAscites fluidNALTQ-Orbitrap XLOvarian cancer Uniquely expressed in ovarian cancer patient 24694173
CancerPDF_ID8864 GELHGLTTEEEFVEGTransthyretinAscites fluidNALTQ-Orbitrap XLOvarian cancer Uniquely expressed in ovarian cancer patient 24694173
CancerPDF_ID8865 GELHGLTTEEEFVEGITransthyretinAscites fluidNALTQ-Orbitrap XLOvarian cancer Uniquely expressed in ovarian cancer patient 24694173
CancerPDF_ID8882 GLTTEEEFVEGTransthyretinAscites fluidNALTQ-Orbitrap XLOvarian cancer Uniquely expressed in ovarian cancer patient 24694173
CancerPDF_ID8997 KAADDTWEPFASGKTSESTransthyretinAscites fluidNALTQ-Orbitrap XLOvarian cancer Uniquely expressed in ovarian cancer patient 24694173
CancerPDF_ID9899 TAVVTNPKETransthyretinSerum479.76LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9900 TTAVVTNPKETransthyretinSerum530.27LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9901 STTAVVTNPKETransthyretinSerum573.79LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9902 YSTTAVVTNPKETransthyretinSerum655.31LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9903 SYSTTAVVTNPKETransthyretinSerum698.82LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9904 YSYSTTAVVTNPKETransthyretinSerum780.35LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9905 EHAEVVFTANDSGPRTransthyretinSerum543.59LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9906 SPYSYSTTAVVTNPKETransthyretinSerum872.4LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9907 HEHAEVVFTANDSGPRTransthyretinSerum589.28LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9908 LLSPYSYSTTAVVTNPKETransthyretinSerum657.34LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9909 YTIAALLSPYSYSTTAVVTNPKETransthyretinSerum830.43LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9910 RYTIAALLSPYSYSTTAVVTNPKETransthyretinSerum882.46LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9911 DSGPRRYTIAALLSPYSYSTTAVVTNPKETransthyretinSerum790.14LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9912 FTANDSGPRRYTIAALLSPYSYSTTAVVTNPKETransthyretinSerum898.48LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID9913 SGPRRYTIAALLSPYSYSTTAVVTNPKETransthyretinSerum761.42LC-MSLung adenocarcinoma "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" 21533267
CancerPDF_ID10088 KVLDAVRGSPAINTransthyretinUrine1339.7643MALDI-TOFMuscle-invasive bladder cancer Differentially expressed between cancer vs normal samples 21805675
CancerPDF_ID10113 TANDSGPRRYTIATransthyretinUrine1421.7142MALDI-TOFMuscle-invasive bladder cancer Differentially expressed between cancer vs normal samples 21805675
CancerPDF_ID10127 VKVLDAVRGSPAINTransthyretinUrine1438.8388MALDI-TOFMuscle-invasive bladder cancer Differentially expressed between cancer vs normal samples 21805675
CancerPDF_ID10183 VKVLDAVRGSPAINVTransthyretinUrine1537.8637MALDI-TOFMuscle-invasive bladder cancer Differentially expressed between cancer vs normal samples 21805675
CancerPDF_ID10676 KVEIDTKSYWKALGISPFHEHAEVVFTransthyretinUrine3030.571MALDI-TOFMuscle-invasive bladder cancer Differentially expressed between cancer vs normal samples 21805675
CancerPDF_ID10715 VAVHVFRKAADDTWEPFASGKTSESGELHGLTTTransthyretinUrine3543.7714MALDI-TOFMuscle-invasive bladder cancer Differentially expressed between cancer vs normal samples 21805675
CancerPDF_ID10721 FVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTransthyretinUrine3738.9299MALDI-TOFMuscle-invasive bladder cancer Differentially expressed between cancer vs normal samples 21805675
CancerPDF_ID10724 AVHVFRKAADDTWEPFASGKTSESGELHGLTTEEETransthyretinUrine3831.8486MALDI-TOFMuscle-invasive bladder cancer Differentially expressed between cancer vs normal samples 21805675
CancerPDF_ID10728 VAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEETransthyretinUrine3930.8524MALDI-TOFMuscle-invasive bladder cancer Differentially expressed between cancer vs normal samples 21805675
CancerPDF_ID10730 VAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFTransthyretinUrine4078.0221MALDI-TOFMuscle-invasive bladder cancer Differentially expressed between cancer vs normal samples 21805675
CancerPDF_ID13937 TAVVTNPKETransthyretinPlasma958.521?LC-MS"Multiple myeloma patients, Acute myeloid leukemia" NA 20974924